The Woodford Equity Income, Lindsell Train Global Equity and Lindsell Train UK Equity funds also made the top 10, as did the AXA Framlington Biotech, Marlborough Multi-Cap Income, Old Mutual UK Alpha and Stewart Investment Asia Pacific Leaders. The in-house HL multi-manager funds Asia and Emerging Markets, Income & Growth Trust, and Special Situations Trust makes up the 10.
Barclays Stockbrokers’ recently issued a list of the most popular Sipp investments for September, which also included the Woodford UK Equity Income and AXA Framlington Biotech finds.
Kevin Morgan, managing director of Hertfordshire-based IFA Consilium Financial Planning, said: “No, there are not many surprises on the list. Of course, [Neil] Woodford’s cachet is huge. He can be seen as a ‘safe’ option because he does not disappoint. But even in the case of Mr Woodford, of course, an adviser will be expected to carry out the necessary due diligence and not just be swayed by ‘Super-Woody’.
“It is good to look for alternatives, and the Marlborough fund has done well over the medium-term. I also favour the Miton Income & Growth fund, which, although small, has a decent yield and is well-managed.”